Skip to content
OpenCapital
Get started

Danaher DHR Biotechnology — Depreciation

Similar metrics at other companies

Ashland logo
ASHLife Sciences — Depreciation
$9M-59.1%
PTC Therapeutics logo
PTCTLife Science — Depreciation
$3.81M+10.1%
INT
INTTProcess Technologies — Depreciation
$54K-12.9%
American Resources Investment Trust Inc logo
INVTechnology — Depreciation, Nonproduction
$342K+136%
Ligand Pharmaceuticals logo
LGNDDevelopment and Licensing of Biopharmaceutical Assets — Depreciation
$119K-76.8%
Flotek Industries logo
FTKChemistry Technologies — Depreciation
$200K0.0%

Other financials

Income statement

See full
Revenue$6.3B+5.5%
Gross profit$3.6B+2.5%
Operating income$1.1B+48.3%
Net income$870.0M+56.8%
EPS (diluted)$1.23+59.7%

Balance sheet

See full
Cash & equivalents$4.3B+47.0%
Total debt$27.9B+50.1%
Total equity$52.6B+0.5%
Total assets$92.4B+13.2%

Cash flow

See full
Operating cash flow$1.5B+14.6%
CapEx$269.0M+8.5%
Free cash flow$1.3B+16.1%

Valuation

See full
Market cap$134.62B-7.4%
Enterprise value$158.13B-1.7%
P/E33.6×-9.0×
P/S5.4×-0.7×

Profitability

See full
Gross margin58.5%-1.1pp
Operating margin20.4%+2.0pp
Net margin15.9%+1.7pp
FCF margin21.8%+1.5pp

Returns & leverage

See full
Return on equity7.6%+1.0pp
Debt / equity0.5×+0.2×
Current ratio1.7×0.0×

Where this comes from

Reported directly by Danaher in its filing.

Tagged under the XBRL concept us-gaap:Depreciation.

The official record: Danaher’s 10-Q, filed July 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about Danaher's biotechnology — depreciation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Danaher's biotechnology — depreciation?
Danaher (DHR) reported biotechnology — depreciation of $40M in Q2 2026.
How has Danaher's biotechnology — depreciation changed year-over-year?
Danaher's biotechnology — depreciation increased by 5.3% year-over-year, from $38M to $40M.
What is the long-term trend for Danaher's biotechnology — depreciation?
Over 2 years (2023 to 2025), Danaher's biotechnology — depreciation has grown at a -4.1% compound annual growth rate (CAGR), from $162M to $149M.
What does biotechnology — depreciation mean?
The systematic allocation of the cost of tangible fixed assets over their useful lives within the biotechnology segment. This reflects the wear and tear of manufacturing equipment and facilities used to produce scientific instruments. It is a non-cash expense that impacts the segment's reported operating profitability.